MENU
ADXN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Addex Therapeutics (ADXN) Ownership - Who owns Addex Therapeutics?

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company... Show more

Profile

Industry
N/A
Address
Chemin des Aulx 12
Phone
+41 228841555
Employees
24
Web
https://www.addextherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.16M
P/E Ratio
N/A
Total Cash
2.19M
Projected Growth
N/A
Total Debt
36.55K
Revenue
31.23K
Risk (Beta)
1.31
Dividend Yield
N/A
Total Cash/Share
1.78
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price

Fundamentals

ADXN
Capitalization
10.2M
P/E Ratio
N/A
Risk (Beta)
1.31
Dividend Yield
N/A
Total Cash
2.19M
Total Cash/Share
1.78
Total Debt
36.5K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
31.2K
ROE
N/A
Book Value
5.96M
P/B Ratio
1.45
Cash Flow
N/A
Earnings
-7.2
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.84M
Current Ratio
2.01
Current Revenue Per Employee
14862.00
Dividends Per Share - Security
N/A
EBITDA
-6.17M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-62.54
Shares Held By Institutions
1.86K
Shares Outstanding - Current
1.23M
Total Liabilities
1.37M
Total Volume MTD
N/A
Value
N/A
Gain YTD
13.990
View a ticker or compare two or three
ADXN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Chemin des Aulx 12
Phone
+41 228841555
Employees
24
Web
https://www.addextherapeutics.com